DHA on liver By Millette Burgos 03-Mar-2017 - Last updated on 08-Nov-2023 at 12:15 GMT Facebook Twitter Linkedin Email to a friend New meta-analysis from China “provides substantial evidence” that n-3 polyunsaturated fatty acid (PUFA) supplementation, especially DHA, can play a positive role in the treatment of non-alcoholic fatty liver disease (NAFLD). GALLERY: Our top 10 most-read health and nutrition stories from February Red Seaweed as potential aid for cancer treatment: Study Revealed: The top five supplements taken by Chinese mothers...and why more needs to be done to increase use Boosting Asia’s brain health: ‘We’re trying to change the slope of cognitive decline’, says supplements boss Curcumin can be ‘as big as omega-3’ with correct science and marketing: OmniActive MD No evidence of link between fruit and veg consumption and reduction in overall cancer cases: Major Japan study ‘Substantial evidence’ that DHA has a favourable effect on liver disease treatment: Meta-analysis ‘Toxic side effects’ and ‘weak regulation’? Not for supplements made in Australia insists trade body Blackmores institute: It's vital we help pharmacists enhance supplements knowledge India fortification plans: Regulator FSSAI releases consultation paper Vitamin vending machines: Is this the future for supplements retailing in APAC? Prev 1 … 5 6 7 8 9 … 11 Next
